June 2018 |
|
Roll Call Opinion: To Keep Drug Costs Low, Think Competition, Not Price Controls
|
|
Hatch Announces Hearing for IRS Nominee Rettig
|
|
Senate Finance GOP to Ross: Tariffs Hurt Americans
|
|
Six Months of Jobs, Growth and Optimism
|
|
Hatch Highlights Benefits of New Tax Law on Six-Month Anniversary
|
|
Hatch Opening Statement at Hearing on 232 Trade Actions
|
|
Breaking Down Section 232 of the Trade Expansion Act of 1962
|
|
Hatch Announces Hearing on Prescription Drug Affordability and Innovation with HHS Secretary Azar
|
|
Hatch Statement on Section 301 Trade Announcement
|
|
Senate Finance Committee’s HEAL Act, A Critical Step Toward Tackling the Opioid Crisis
|
|
Hatch Announces Hearing to Examine Tariff Actions by Department of Commerce
|
|
Finance Committee Advances Legislation to Address Opioid Epidemic
|
|
Hatch Opening Statement at Markup of Legislation to Address Opioid Crisis
|
|
Hatch Opening Statement at Trade, Tax Nominations Hearing
|
|
Hatch Statement on Appointment of Jeremy Keele to the Commission on Social Impact Partnerships
|